The WHO 2016 verbal autopsy instrument: An international standard suitable for automated analysis by InterVA, InSilicoVA, and Tariff 2.0
Erin Nichols and colleagues describe the development of the WHO verbal autopsy standard instrument
Vyšlo v časopise:
The WHO 2016 verbal autopsy instrument: An international standard suitable for automated analysis by InterVA, InSilicoVA, and Tariff 2.0. PLoS Med 15(1): e32767. doi:10.1371/journal.pmed.1002486
Kategorie:
Guidelines and Guidance
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002486
Souhrn
Erin Nichols and colleagues describe the development of the WHO verbal autopsy standard instrument
Zdroje
1. United Nations Statistics Division. Demographic and Social Statistics. 2017. Available from: http://unstats.un.org/unsd/demographic/CRVS/CR_coverage.htm (accessed 23 March 2017).
2. World Health Organization. World Health Statistics 2013. Geneva, Switzerland: World Health Organization 2013.
3. World Health Organization. World Health Organization Map Production. Public Health Information and Geographic Information Systems (GHIS). Geneva, Switzerland: World Health Organization 2015.
4. Lopez AD, Setel PW. Better health intelligence: a new era for civil registration and vital statistics? BMC Med. 2015;13:73. doi: 10.1186/s12916-015-0333-4 25885782
5. Fottrell E, Byass P. Verbal autopsy: methods in transition. Epidemiol Rev. 2010;32:38–55. doi: 10.1093/epirev/mxq003 20203105
6. Murray CJ, Lozano R, Flaxman AD, Serina P, Phillips D, Stewart A, et al. Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med. 2014;12:5. doi: 10.1186/1741-7015-12-5 24405531
7. Second Global Congress on Verbal Autopsy. Rhodes, Greece. October 14–16, 2013. Available from: http://www.healthdata.org/events/meeting/second-global-congress-verbal-autopsy (accessed 23 March 2017).
8. World Health Organization. Final report: Review of the literature and currently-used verbal autopsy tools. WHO Technical Consultation on Verbal Autopsy Tools. Talloires, France: World Health Organization, 2004.
9. World Health Organization. Verbal autopsy standards: ascertaining and attributing causes of death. Geneva, Switzerland: World Health Organization 2007.
10. World Health Organization. Verbal autopsy standards: Ascertaining and attributing causes of death. The 2012 WHO verbal autopsy instrument. Release Candidate 1. Geneva, Switzerland: World Health Organization 2012. Available from: http://www.who.int/healthinfo/statistics/verbalautopsystandards/en/index2.html (accessed 23 March 2017).
11. Scanlon P, Nichols E. Results of the Cognitive Interviewing Study of the 2012 WHO Verbal Autopsy Instrument in Nyanza Province, Kenya. Hyattsville, MD, USA: National Center for Health Statistics, 2014.
12. World Health Organization. Verbal autopsy standards: the 2014 WHO verbal autopsy instrument. Geneva, Switzerland: World Health Organization 2014. Available from: http://www.who.int/healthinfo/statistics/verbalautopsystandards/en/index1.html (accessed 23 March 2017).
13. Byass P, Chandramohan D, Clark SJ, D'Ambruoso L, Fottrell E, Graham WJ, et al. Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action. 2012;5(1):19281. doi: 10.3402/gha.v5i0.19281 28140847
14. McCormick TH, Li ZR, Calvert C, Crampin AC, Kahn K, Clark SJ. Probabilistic Cause-of-death Assignment using Verbal Autopsies. J Am Stat Assoc. 2016;111(515):1036–49. doi: 10.1080/01621459.2016.1152191 27990036
15. Serina P, Riley I, Stewart A, James SL, Flaxman AD, Lozano R, et al. Improving performance of the Tariff Method for assigning causes of death to verbal autopsies. BMC Med. 2015;13:291. doi: 10.1186/s12916-015-0527-9 26644140
16. World Health Organization. Verbal autopsy standards: the 2016 WHO verbal autopsy instrument. Geneva, Switzerland: World Health Organization 2016. Available from: http://www.who.int/healthinfo/statistics/verbalautopsystandards/en/ (accessed 23 March 2017).
17. Hartung C, Lerer A, Anokwa Y, Tseng C, Brunette W, Borriello G. Open Data Kit: tools to build information services for developing regions. Proceedings of the 4th ACM/IEEE International Conference on Information and Communication Technologies and Development; London, United Kingdom. 2369236: ACM; 2010;1–12.
18. Streatfield PK, Khan WA, Bhuiya A, Alam N, Sie A, Soura AB, et al. Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Glob Health Action. 2014;7:25362.
19. Bird J, Byass P, Kahn K, Mee P, Fottrell E. A matter of life and death: practical and ethical constraints in the development of a mobile verbal autopsy tool. Proceedings of the SIGCHI Conference on Human Factors in Computing Systems; Paris, France. 2466198: ACM; 2013;1489–98.
20. Murray CJ, Lopez AD, Black R, Ahuja R, Ali SM, Baqui A, et al. Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr. 2011;9:27. doi: 10.1186/1478-7954-9-27 21816095
21. James SL, Flaxman AD, Murray CJ. Performance of the Tariff Method: validation of a simple additive algorithm for analysis of verbal autopsies. Popul Health Metr. 2011;9:31. doi: 10.1186/1478-7954-9-31 21816107
22. Serina P, Riley I, Stewart A, Flaxman AD, Lozano R, Mooney MD, et al. A shortened verbal autopsy instrument for use in routine mortality surveillance systems. BMC Med. 2015;13:302. doi: 10.1186/s12916-015-0528-8 26670275
23. Setel PW, Rao C, Hemed Y, Whiting DR, Yang G, Chandramohan D, et al. Core verbal autopsy procedures with comparative validation results from two countries. PLoS Med. 2006;3(8):e268. doi: 10.1371/journal.pmed.0030268 16942391
24. Wang L, Yang G, Jiemin M, Rao C, Wan X, Dubrovsky G, et al. Evaluation of the quality of cause of death statistics in rural China using verbal autopsies. J Epidemiol Community Health. 2007;61(6):519–26. doi: 10.1136/jech.2005.043927 17496261
25. Polprasert W, Rao C, Adair T, Pattaraarchachai J, Porapakkham Y, Lopez AD. Cause-of-death ascertainment for deaths that occur outside hospitals in Thailand: application of verbal autopsy methods. Popul Health Metr. 2010;8:13. doi: 10.1186/1478-7954-8-13 20482760
26. Hoa NP, Rao C, Hoy DG, Hinh ND, Chuc NT, Ngo DA. Mortality measures from sample-based surveillance: evidence of the epidemiological transition in Viet Nam. Bull World Health Organ. 2012;90(10):764–72. doi: 10.2471/BLT.11.100750 23109744
27. Rao C, Kosen S, Bisara D, Usman Y, Adair T, Djaja S, et al. Tuberculosis mortality differentials in Indonesia during 2007–2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis. 2011;15(12):1608–14. doi: 10.5588/ijtld.11.0018 22118166
28. Franca E, Teixeira R, Ishitani L, Duncan BB, Cortez-Escalante JJ, Morais Neto OL, et al. Ill-defined causes of death in Brazil: a redistribution method based on the investigation of such causes. Rev Saude Publica. 2014;48(4):671–81; discussion 81. doi: 10.1590/S0034-8910.2014048005146 25210826
29. Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingra N, et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med. 2006;3(2):e18. doi: 10.1371/journal.pmed.0030018 16354108
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 1
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Traumatic brain injury and the risk of dementia diagnosis: A nationwide cohort study
- Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort
- PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults